XBiotech Inc. - Common Shares, no par value (XBIT)

CUSIP: 98400H102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Shares, no par value
Shares outstanding
32,315,113
Total 13F shares
2,756,801
Share change
-297,502
Total reported value
$9,674,374
Price per share
$3.51
Number of holders
38
Value change
-$1,050,261
Number of buys
8
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 98400H102?
CUSIP 98400H102 identifies XBIT - XBiotech Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2022

As of 31 Dec 2022, XBiotech Inc. - Common Shares, no par value (XBIT) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,756,801 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., CREDIT SUISSE AG/, GEODE CAPITAL MANAGEMENT, LLC, Oasis Management Co Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and TWO SIGMA INVESTMENTS, LP. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.